Head-to-Head

DBV Technologies S.A. American Depositary Shares vs. Halozyme Therapeutics, Inc.

DBVT

DBV Technologies S.A. American Depositary Shares

$9.02 -4.25%

VS HALO

Halozyme Therapeutics, Inc.

$91.35 -1.82%

DBV Technologies S.A. American Depositary Shares and Halozyme Therapeutics, Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

DBVTHALO
Market Cap $566.82 million $10.41 billion

HALO leads on 1 of 1 size & scale factors.

Risk & Sentiment

DBVTHALO
Short Interest 1.06% 9.75%

DBVT leads on 1 of 1 risk & sentiment factors.

Dig deeper: DBVT overview, DBVT financials, HALO overview, HALO financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.